Quality control project of NGS HLA genotyping for the 17th International HLA and Immunogenetics Workshop.


Journal

Human immunology
ISSN: 1879-1166
Titre abrégé: Hum Immunol
Pays: United States
ID NLM: 8010936

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 17 08 2018
revised: 10 01 2019
accepted: 30 01 2019
pubmed: 10 2 2019
medline: 31 7 2019
entrez: 10 2 2019
Statut: ppublish

Résumé

The 17th International HLA and Immunogenetics Workshop (IHIW) organizers conducted a Pilot Study (PS) in which 13 laboratories (15 groups) participated to assess the performance of the various sequencing library preparation protocols, NGS platforms and software in use prior to the workshop. The organizers sent 50 cell lines to each of the 15 groups, scored the 15 independently generated sets of NGS HLA genotyping data, and generated "consensus" HLA genotypes for each of the 50 cell lines. Proficiency Testing (PT) was subsequently organized using four sets of 24 cell lines, selected from 48 of 50 PS cell lines, to validate the quality of NGS HLA typing data from the 34 participating IHIW laboratories. Completion of the PT program with a minimum score of 95% concordance at the HLA-A, HLA-B, HLA-C, HLA-DRB1 and HLA-DQB1 loci satisfied the requirements to submit NGS HLA typing data for the 17th IHIW projects. Together, these PS and PT efforts constituted the 17th IHIW Quality Control project. Overall PT concordance rates for HLA-A, HLA-B, HLA-C, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQB1, HLA-DRB1, HLA-DRB3, HLA-DRB4 and HLA-DRB5 were 98.1%, 97.0% and 98.1%, 99.0%, 98.6%, 98.8%, 97.6%, 96.0%, 99.1%, 90.0% and 91.7%, respectively. Across all loci, the majority of the discordance was due to allele dropout. The high cost of NGS HLA genotyping per experiment likely prevented the retyping of initially failed HLA loci. Despite the high HLA genotype concordance rates of the software, there remains room for improvement in the assembly of more accurate consensus DNA sequences by NGS HLA genotyping software.

Identifiants

pubmed: 30738112
pii: S0198-8859(19)30127-2
doi: 10.1016/j.humimm.2019.01.009
pmc: PMC6446570
mid: NIHMS1521785
pii:
doi:

Substances chimiques

HLA Antigens 0

Types de publication

Journal Article Review

Langues

eng

Pagination

228-236

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI128775
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM109030
Pays : United States
Organisme : Department of Health
ID : RP-PG-0310-1003
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : U19 NS095774
Pays : United States

Informations de copyright

Copyright © 2019 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Références

Int J Immunogenet. 2013 Feb;40(1):1
pubmed: 23280276
Hum Immunol. 2018 Feb;79(2):77-86
pubmed: 29247682
Hum Immunol. 2015 Dec;76(12):887-90
pubmed: 25777625
Methods Mol Biol. 2013;1034:161-95
pubmed: 23775737
Tissue Antigens. 2007 Apr;69 Suppl 1:85-7
pubmed: 17445174
Tissue Antigens. 2013 Aug;82(2):106-12
pubmed: 23849068
Tissue Antigens. 2013 Apr;81(4):194-203
pubmed: 23510415
Int J Immunogenet. 2013 Feb;40(1):60-5
pubmed: 23198982
Methods Mol Biol. 2012;882:9-25
pubmed: 22665226
Hum Immunol. 2013 Oct;74(10):1313-20
pubmed: 23806270
Hum Immunol. 1991 Jul;31(3):186-94
pubmed: 1890020
Immunogenetics. 1990;31(2):112-7
pubmed: 2303277

Auteurs

Kazutoyo Osoegawa (K)

Histocompatibility, Immunogenetics, and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA. Electronic address: kazutoyo@stanford.edu.

Tamara A Vayntrub (TA)

Histocompatibility, Immunogenetics, and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.

Sabine Wenda (S)

Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.

Dianne De Santis (D)

PathWest, Fiona Stanley Hospital, Murdoch, WA, Australia.

Konstantinos Barsakis (K)

Histocompatibility, Immunogenetics, and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA; University of Crete, Biology Department, Heraklion, Greece; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

Milena Ivanova (M)

Alexandrovska Hospital, Sofia, Bulgaria.

Susan Hsu (S)

Histocompatibility/Molecular Genetics, American Red Cross, Philadelphia, PA, USA.

Jonathan Barone (J)

Histocompatibility/Molecular Genetics, American Red Cross, Philadelphia, PA, USA.

Rhonda Holdsworth (R)

Australian Red Cross Blood Services, Melbourne, Australia.

Mary Diviney (M)

Australian Red Cross Blood Services, Melbourne, Australia.

Medhat Askar (M)

Baylor University Medical Center, Dallas, TX, USA.

Amanda Willis (A)

Baylor University Medical Center, Dallas, TX, USA.

Dawn Railton (D)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Sophie Laflin (S)

Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.

Ketevan Gendzekhadze (K)

City of Hope National Medical Center, Duarte, CA, USA.

Arisa Oki (A)

City of Hope National Medical Center, Duarte, CA, USA.

Nicoletta Sacchi (N)

Ente Ospedaliero Ospedali Galliera, Genova, Italy.

Michela Mazzocco (M)

Ente Ospedaliero Ospedali Galliera, Genova, Italy.

Marco Andreani (M)

Fondazione I.M.E. Istituto Mediterraneo Di Ematologia, Rome, Italy.

Reem Ameen (R)

Health Sciences Center, Kuwait University, Jabriya, Kuwait.

Catherine Stavropoulos-Giokas (C)

Hellenic Cord Blood Bank, Athens, Greece.

Amalia Dinou (A)

Hellenic Cord Blood Bank, Athens, Greece.

Margareth Torres (M)

Hospital Albert Einstein, Sao Paulo, Brazil.

Rodrigo Dos Santos Francisco (R)

Hospital Albert Einstein, Sao Paulo, Brazil.

Carles Serra-Pages (C)

Centro de Diagonóstico Biomédico, Hospital Clínic de Barcelona, Barcelona, Spain.

Damian Goodridge (D)

Illumina, Inc., San Diego, CA, USA.

Sandra Balladares (S)

Illumina, Inc., San Diego, CA, USA.

Maria P Bettinotti (MP)

Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Brian Iglehart (B)

Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Zahra Kashi (Z)

Kashi Clinical Laboratories, Inc., Portland, OR, USA.

Russell Martin (R)

Kashi Clinical Laboratories, Inc., Portland, OR, USA.

Chee Loong Saw (CL)

McGill University Health Centre, Montreal, QC, Canada.

Jiannis Ragoussis (J)

McGill University Health Centre, Montreal, QC, Canada; Department of Human Genetics, McGill University, Montreal, Quebec, Canada.

Jonathan Downing (J)

New Zealand Blood Service, Epsom, Auckland, New Zealand.

Cristina Navarrete (C)

National H&I Service Development Laboratory NHS Blood and Transplant, London, UK.

Winnie Chong (W)

National H&I Service Development Laboratory NHS Blood and Transplant, London, UK.

Katsuyuki Saito (K)

One Lambda, Thermo Fisher Scientific, Canoga Park, CA, USA.

Martin Petrek (M)

Palacky University, Faculty of Medicine and Dentistry, Olomouc, Czech Republic.

Stana Tokic (S)

Palacky University, Faculty of Medicine and Dentistry, Olomouc, Czech Republic.

Karin Padros (K)

Primer Centro Argentino de Immunogenetica (PRICAI), Fundación Favaloro, CABA, Argentina.

Ma Beatriz Rodriguez (M)

Primer Centro Argentino de Immunogenetica (PRICAI), Fundación Favaloro, CABA, Argentina.

Viktoria Zakharova (V)

Rogachev Federal Research Centre of Pediatric Hematology,Oncology and Immunology, Moscow, Russian Federation.

Olga Shragina (O)

Rogachev Federal Research Centre of Pediatric Hematology,Oncology and Immunology, Moscow, Russian Federation.

Susana R Marino (SR)

The University of Chicago Medicine, Chicago, IL, USA.

Nicholas K Brown (NK)

The University of Chicago Medicine, Chicago, IL, USA.

Takashi Shiina (T)

Tokai University School of Medicine, Kanagawa, Japan.

Shingo Suzuki (S)

Tokai University School of Medicine, Kanagawa, Japan.

Eric Spierings (E)

University Medical Center Utrecht, Netherlands.

Qiuheng Zhang (Q)

University of California, Los Angeles, Immunogenetics Center, Los Angeles, CA, USA.

Yuxin Yin (Y)

University of California, Los Angeles, Immunogenetics Center, Los Angeles, CA, USA.

Gerald P Morris (GP)

University of California San Diego, La Jolla, CA, USA.

Ana Hernandez (A)

University of Miami Miller School of Medicine, USA.

Phillip Ruiz (P)

University of Miami Miller School of Medicine, USA.

Seik-Soon Khor (SS)

University of Tokyo, Tokyo, Japan.

Katsushi Tokunaga (K)

University of Tokyo, Tokyo, Japan.

Aviva Geretz (A)

Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.

Rasmi Thomas (R)

Walter Reed Army Institute of Research, Silver Spring, MD, USA; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.

Fumiko Yamamoto (F)

Histocompatibility, Immunogenetics, and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.

Kalyan C Mallempati (KC)

Histocompatibility, Immunogenetics, and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.

Sridevi Gangavarapu (S)

Histocompatibility, Immunogenetics, and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA.

Uma Kanga (U)

All India Institute of Medical Sciences, New Delhi, India.

Shweta Tyagi (S)

All India Institute of Medical Sciences, New Delhi, India.

Steven G E Marsh (SGE)

Anthony Nolan Research Institute and UCL Cancer Institute, Royal Free Campus, London, UK.

Will P Bultitude (WP)

Anthony Nolan Research Institute and UCL Cancer Institute, Royal Free Campus, London, UK.

Xiangjun Liu (X)

Bo Fu Rui (BFR) Transplant Diagnostics, Beijing, China.

Dajiang Cao (D)

Bo Fu Rui (BFR) Transplant Diagnostics, Beijing, China.

Maarten Penning (M)

GenDx, Utrecht, Netherlands.

Carolyn K Hurley (CK)

Georgetown University Medical Center, Washington DC, USA.

Anne Cesbron (A)

Histocompatibility and Immunogenetics Laboratory, Nantes, France.

Claudia Mueller (C)

Transplantation and Immunology, Universitat Tuebingen, Germany.

Joannis Mytilineos (J)

Transplantation Immunology, Ulm, Germany.

Eric T Weimer (ET)

Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill School of Medicine, NC, USA.

Mats Bengtsson (M)

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.

Gottfried Fischer (G)

Department of Blood Group Serology and Transfusion Medicine, Medical University of Vienna, Vienna, Austria.

John A Hansen (JA)

Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.

Chia-Jung Chang (CJ)

Stanford Genome Technology Center, Palo Alto, CA, USA.

Steven J Mack (SJ)

Center for Genetics, Children's Hospital Oakland Research Institute, Oakland, CA, USA.

Lisa E Creary (LE)

Histocompatibility, Immunogenetics, and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

Marcelo A Fernandez-Viña (MA)

Histocompatibility, Immunogenetics, and Disease Profiling Laboratory, Stanford Blood Center, Palo Alto, CA, USA; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH